Researchers at the MRC Epidemiology Unit and the Primary Care Unit have started work on an NIHR Programme Grant for Applied Research to develop and evaluate scalable behavioural weight management programmes to prevent and treat type 2 diabetes (T2D). The grant provides £2 million over 4.5 years and is led by Dr Amy Ahern and […]
Little known about impact of widely prescribed diabetes drug, metformin, on cardiovascular disease
Metformin is the most-prescribed oral medication to lower blood glucose worldwide. But research findings about its association with cardiovascular disease, the most costly complication of type 2 diabetes, remain sparse and difficult to interpret. A new meta-analysis of research on the effect of metformin on cardiovascular outcomes in diabetes patients shows that metformin monotherapy appears […]
Large studies find screening reduces mortality for those with detectable type 2 diabetes but not for general population
Three large trials involving researchers from the MRC Epidemiology Unit and the Department of Public Health and Primary Care show that screening for type 2 diabetes and cardiovascular risk factors may not reduce mortality and cardiovascular disease in the general population. However, for individuals diagnosed with diabetes, screening is associated with a reduction in mortality […]
Type 2 Diabetes – would you risk it?
Does personalized genetic information help people adopt healthier behaviour? Giving people information about their individual risk of developing type 2 diabetes does not influence them to change their health-related behaviours, according to a study led by researchers from the MRC Epidemiology Unit, University of Cambridge and published today in PLOS Medicine. Being more physically active […]